Shattuck Labs, Inc. (STTK)

10.13 +0.35 (+3.58%) As of 12:27PM EDT. Market open.

Shattuck Labs, Inc.

500 West 5th Street
Suite 1200
Austin, TX 78701
United States
512 900 4690
https://www.shattucklabs.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 75

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Casi DeYoung	Chief Business Officer	523.48k	N/A	1971
Dr. Thomas Lampkin Pharm.D.	Senior Vice President of Regulatory Affairs	N/A	N/A	N/A
Mr. George Fromm Ph.D.	Chief Scientific Officer of ARC Platform	N/A	N/A	N/A
Mr. Suresh de Silva Ph.D.	Chief Scientific Officer of GADLEN Platform	N/A	N/A	N/A
Ms. Kelli Collin M.S.	Senior Vice President of Quality	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.

Corporate governance

Shattuck Labs, Inc.’s ISS governance QualityScore as of 1 April 2024 is 6. The pillar scores are Audit: 4; Board: 6; Shareholder rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.